DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

26.58B

Market cap26.58B

Price-Earnings ratio

29.54

Price-Earnings ratio29.54

Dividend yield

—

Dividend yield—

Average volume

5.52M

Average volume5.52M

High today

$70.27

High today$70.27

Low today

$68.72

Low today$68.72

Open price

$70.24

Open price$70.24

Volume

5.62M

Volume5.62M

52 Week high

$89.98

52 Week high$89.98

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

As of today, DexCom(DXCM) shares are valued at $68.92. The company's market cap stands at 26.58B, with a P/E ratio of 29.54.

As of 2026-06-24, DexCom(DXCM) stock has fluctuated between $68.72 and $70.27. The current price stands at $68.92, placing the stock +0.3% above today's low and -1.9% off the high.

The DexCom(DXCM)'s current trading volume is 5.62M, compared to an average daily volume of 5.52M.

In the last year, DexCom(DXCM) shares hit a 52-week high of $89.98 and a 52-week low of $54.11.

DXCM News

TipRanks 16h

DexCom initiated with a Buy at Deutsche Bank

Deutsche Bank initiated coverage of DexCom (DXCM) with a Buy rating and $86 price target The company “could be turning a corner” as its recent investor day ease...

TipRanks 17h

DexCom announces milestones to make glucose biosensing more accessible

DexCom (DXCM) announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible. The company announce...

Simply Wall St 4d

DexCom Stock Could Be 13.1% Undervalued After Pediatric Stelo Clearance

DexCom (DXCM) is back in focus after US regulators cleared its Stelo Glucose Biosensor System as the first over-the-counter continuous glucose monitor for child...

Analyst ratings

84%

of 32 ratings

Buy

84.4%

Hold

15.6%

Sell

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.